TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$58 Million

Invitae Corp.

Follow-on Offering

Bookrunner, March 2018

Invitae Corp.
Invitae is a medical genetics company whose mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae offers high quality, comprehensive, affordable genetic testing across multiple clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, metabolic conditions and rare diseases